Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs J B Hunt Transport Services Inc (JBHT) Price & Performance

BioNTech SE - ADRTrade
J B Hunt Transport Services IncTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs J B Hunt Transport Services Inc — how do they compare? BioNTech SE - ADR trades at $93.06 (market cap $23.31B), while J B Hunt Transport Services Inc trades at $275.51 (market cap $24.92B). The key difference: BioNTech SE - ADR and J B Hunt Transport Services Inc are close in size by market cap, and J B Hunt Transport Services Inc pays a 0.68% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

BNTXJBHT
Market Cap
$23.31B$24.92B
Sector
HealthIndustrials
52-Week High
$119.34$298.41
52-Week Low
$83.89$130.65
Enterprise Value
$6.60B$26.06B
Dividend Yield
0.68%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNTech SE - ADR

BioNTech (BNTX) trades at $93.27, up 0.51% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q2 2026 revenue of $106 million, missing expectations, and lowered its full-year sales outlook due to weak COVID-19 vaccine demand. Despite negative net income margins and cash outflows, BNTX maintains a strong cash position of $16.78 billion and is advancing its oncology pipeline with 14 pivotal clinical trials.

The outlook is mixed: analyst consensus is strongly bullish with a $121 price target, but declining COVID revenue and ongoing losses pose significant risks. Investment opportunity hinges on successful pipeline development, while near-term headwinds from vaccine demand softness and leadership transition require careful monitoring.

J B Hunt Transport Services Inc

JBHT trades at $275.5, up 3.52% today, with a bearish technical signal but strong analyst consensus. The company reported revenue of $12.0B in 2025, with net income of $598.28M and a 5.31% net margin. Recent earnings have consistently beaten estimates, and the company announced a $0.45 dividend payable in August 2026. Cash flow from operations remains robust at $1.68B in 2025, though net cash flow was slightly negative.

The outlook is positive with a consensus price target of $299.82, implying 8.8% upside. Risks include competitive pressures and macroeconomic volatility, but strong institutional ownership and a buy rating from 57.8% of analysts support a favorable view. The stock's valuation multiples are elevated, but earnings growth and intermodal demand recovery provide catalysts.

Returns comparison

Trailing returns across standard periods

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About J B Hunt Transport Services Inc

J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).

Read more on JBHT